These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 8352569

  • 1. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.
    Pérez V, Pierré A, Léonce S, Anstett M, Atassi G.
    Anticancer Res; 1993; 13(4):985-90. PubMed ID: 8352569
    [Abstract] [Full Text] [Related]

  • 2. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V, Pierré A, Léonce S, Anstett M, Prost JF, Atassi G.
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [Abstract] [Full Text] [Related]

  • 3. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry.
    Sebille S, Morjani H, Poullain MG, Manfait M.
    Anticancer Res; 1994 Apr; 14(6A):2389-93. PubMed ID: 7825978
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacological properties of S9788, a new modulator of multidrug resistance].
    Bull Cancer; 1994 Feb; 81(2):93-103. PubMed ID: 7894124
    [Abstract] [Full Text] [Related]

  • 5. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
    Julia AM, Roché H, Berlion M, Lucas C, Milano G, Robert J, Bizzari JP, Canal P.
    Br J Cancer; 1994 May; 69(5):868-74. PubMed ID: 8180016
    [Abstract] [Full Text] [Related]

  • 6. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1707-15. PubMed ID: 1360210
    [Abstract] [Full Text] [Related]

  • 7. Effects of verapamil and S9788 on MDR-1 mRNA expression studied by in situ hybridization.
    Joly P, Lallemand A, Oum'Hamed Z, Trentesaux C, Idoine O, Desplaces A.
    Anticancer Res; 1996 Nov 03; 16(6B):3609-14. PubMed ID: 9042229
    [Abstract] [Full Text] [Related]

  • 8. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
    Merlin JL, Marchal S, Ramacci C, Dieterlen A, Schultz G, Lucas C, Poullain MG, Berlion M.
    Cytometry; 1995 Aug 01; 20(4):315-23. PubMed ID: 7587719
    [Abstract] [Full Text] [Related]

  • 9. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT, Cirtain MC, Look AT, Ashmun RA.
    Cancer Res; 1986 Feb 01; 46(2):778-84. PubMed ID: 3455678
    [Abstract] [Full Text] [Related]

  • 10. [Effect of the modality of exposure on the action of S9788 on the modulation of multidrug resistance of human tumor cell lines].
    Merlin JL, Marchal S, Ramacci C, Lucas C, Paraire M, Poullain MG.
    Bull Cancer; 1994 Oct 01; 81(10):906-9. PubMed ID: 7734778
    [No Abstract] [Full Text] [Related]

  • 11. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
    Breier A, Drobná Z, Barancík M.
    Neoplasma; 1998 Oct 01; 45(4):248-53. PubMed ID: 9890669
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
    Massart C, Gibassier J, Raoul M, Pourquier P, Leclech G, Robert J, Lucas C.
    Anticancer Drugs; 1995 Feb 01; 6(1):135-46. PubMed ID: 7756676
    [Abstract] [Full Text] [Related]

  • 13. [Difference between the effects of S9788, verapamil and quinine on the reversion of multidrug resistance in two human tumor cell lines].
    Bennis S, Robert J.
    Bull Cancer; 1994 Oct 01; 81(10):886-90. PubMed ID: 7734772
    [No Abstract] [Full Text] [Related]

  • 14. R-dl-verapamil downmodulates multidrug resistance of KBv200 cells to vincristine and doxorubicin.
    Fang G, Yang YL, Li JS, Zhang ZX.
    Zhongguo Yao Li Xue Bao; 1999 Jul 01; 20(7):647-50. PubMed ID: 10678132
    [Abstract] [Full Text] [Related]

  • 15. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
    Belhoussine R, Morjani H, Manfait M.
    Bull Cancer; 1997 Apr 01; 84(4):343-9. PubMed ID: 9238156
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro.
    Hill BT, van der Graaf WT, Hosking LK, de Vries EG, Mulder NH, Whelan RD.
    Int J Cancer; 1993 Sep 09; 55(2):330-7. PubMed ID: 8103761
    [Abstract] [Full Text] [Related]

  • 17. Verapamil reversal of vincristine resistance and cross-resistance patterns of vincristine-resistant Chinese hamster ovary cells.
    Brewer F, Warr JR.
    Cancer Treat Rep; 1987 Apr 09; 71(4):353-9. PubMed ID: 2881620
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
    Watanabe Y, Takano H, Kiue A, Kohno K, Kuwano M.
    Anticancer Drug Des; 1991 Feb 09; 6(1):47-57. PubMed ID: 2015041
    [Abstract] [Full Text] [Related]

  • 19. Novel multidrug resistance reversal agents.
    Berger D, Citarella R, Dutia M, Greenberger L, Hallett W, Paul R, Powell D.
    J Med Chem; 1999 Jun 17; 42(12):2145-61. PubMed ID: 10377220
    [Abstract] [Full Text] [Related]

  • 20. Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells.
    Huet S, Chapey C, Robert J.
    Eur J Cancer; 1993 Jun 17; 29A(10):1377-83. PubMed ID: 8398262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.